Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
05/2004
05/21/2004WO2004041816A1 Azacyclic compounds as orexin receptor antagonist
05/20/2004US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
05/20/2004US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
05/20/2004US20040097561 Benzamides and related inhibitors of factor Xa
05/20/2004US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
05/20/2004US20040097487 To inhibits matrix metalloprotease activity
05/19/2004EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors
05/18/2004US6737425 N,N-substituted cyclic amine derivatives
05/18/2004US6737142 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer
05/13/2004WO2004039795A2 Amide compounds for the treatment of hyperlipidemia
05/13/2004WO2004026305A9 Diaryl ethers as opioid receptor antagonist
05/13/2004US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
05/13/2004US20040092728 Using halodimethylsulfonium halide as activated nucleophilic agent
05/13/2004US20040092553 Excitatory amino acid receptor modulators
05/13/2004US20040092521 Antihistamines; central nervous system disorders
05/13/2004US20040092507 Melanocortin receptor agonists
05/13/2004US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents
05/13/2004US20040092498 Substituted glycine derivatives for use as medicaments
05/12/2004EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor
05/12/2004EP1052984B1 Antibacterial agents
05/12/2004CN1495188A Substituted tetrels metal complex, catalyst and olefin polymerization method
05/11/2004US6734303 Therapy for benign prostatic hyperplasia
05/11/2004US6734189 Hydroxamic and carboxylic acid derivatives
05/11/2004US6734182 Aryl sulfonamides and sulfamide derivatives and uses thereof
05/06/2004WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087798 Novel amide compounds
05/06/2004US20040087585 Peptide deformylase inhibitors
05/06/2004US20040087568 Substituted anthranilic amide derivatives and methods of use
05/06/2004EP1414455A1 Isoquinoline inhibitors of p38
05/05/2004CN1494425A Carboxamide derivatives as therapeutic agents
05/05/2004CN1148349C N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor
05/04/2004US6730789 Radiation resistance, weatherproof, washfastness, colorfastness; hair dyes
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730682 Herpes virus
04/2004
04/29/2004WO2003104282A8 Glycoprotein vi - fc fusion protein for treating vascular disorders
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/29/2004WO2002083842A9 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
04/29/2004US20040082780 Vanilloid receptor ligands and their use in treatments
04/29/2004US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor
04/29/2004US20040082607 Fused heterocyclic compounds
04/29/2004US20040082590 Dietetics; antidiabetic agents; sexual disorders
04/29/2004US20040082575 Compounds and methods for modulation of estrogen receptors
04/29/2004US20040082567 Antiproliferative agents; anticancer agents; fungicides; antiinflammatory agents
04/28/2004EP1412331A1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines
04/28/2004EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/28/2004EP1051394B1 Potassium channel inhibitors
04/28/2004EP0558648B1 Improved matrix metalloprotease inhibitors
04/28/2004CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor
04/27/2004US6726972 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
04/22/2004WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
04/22/2004US20040077657 HT3 Receptor antagonists; amyotrophic lateral sclerosis, premenstrual tension, obsessive-compulsive disorder; Parkinson*s, Alzheimer*s, and Huntington*s disease; memory, eating, psychological, and nervous system disorders
04/22/2004US20040077646 Indole nitriles
04/22/2004US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
04/21/2004EP1411049A1 Estrogen Agonists/Antagonists
04/21/2004EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
04/21/2004EP1149079B1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
04/21/2004CN1146543C Serine protease inhibitor
04/20/2004US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis
04/20/2004US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2)
04/20/2004US6723730 Capsaicin receptor ligands
04/15/2004WO2004031248A1 Novel nitrosation polymer in organic synthesis
04/15/2004US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072850 Caspase inhibitors and uses thereof
04/15/2004US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents
04/15/2004US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
04/15/2004CA2500754A1 Novel nitrosation polymer in organic synthesis
04/14/2004EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
04/14/2004CN1145611C Method for purifying isoquinoline
04/13/2004US6720317 Inhibitors of factor Xa
04/08/2004WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
04/08/2004US20040068020 Patient oxygenation using stabilized fluorocarbon emulsions
04/08/2004US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
04/08/2004US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
04/06/2004US6716983 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
04/06/2004US6716866 Aryl-benzimidazole compounds having antiinfective activity
04/06/2004US6716853 Degenerative joint disorders; 2-(4'-alkyloxycarbonylaminobi phenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxy or the 4,5,6,7-tetrahydro-1h-imidazo(4,5-c)pyridine ring; sulfonylation of ring n with 4-nitrobiphenylsulfonic acid
04/06/2004US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes
04/01/2004WO2004026823A1 Amide and sulfonamide ligands for the estrogen receptor
04/01/2004WO2004026305A1 Diaryl ethers as opioid receptor antagonist
04/01/2004WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
04/01/2004WO2003104199A3 Iminium salts in cleaning compositions
04/01/2004WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
04/01/2004WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
04/01/2004WO2003066597A3 Guanidino compounds
04/01/2004US20040063959 Esters and amides as PLA2 inhibitors
04/01/2004CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor
03/2004
03/31/2004EP1403253A1 Novel heterocyclic compound and medicinal use thereof
03/31/2004EP1402890A1 Sulfonamide derivatives
03/31/2004EP1401821A1 Novel phenylalkyl diamine and amide analogs
03/31/2004EP1401817A1 Isoquinoline compounds having antiinfective activity
03/31/2004EP1299401B1 Chiral ligands for asymmetric catalysis
03/31/2004CN1486308A Piperazinylcarbonylquinolines and -isoquinolines
03/31/2004CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis
03/31/2004CN1143850C Menispermum dahuricum dc.extract,the extractive process and the application thereof
03/30/2004US6713650 ABCA-1 elevating compounds
03/30/2004US6713146 Singly recordable compact disc (cd-r)
03/25/2004WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
03/25/2004WO2004024694A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 119